Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
As part of its efforts to keep ahead of big pharma in discovering more medicines for cardiometabolic disorders In November 2023, Novo Nordisk A/S announced that it planned to introduce its immensely popular anti-obesity medicine, Wegovy, in Japan on February 22, marking its first launch in Asia, even as it struggles to keep up with demand in existing regions SKU- Interactive Data Analysis Dashboard Company Analysis Dashboard for high growth potential opportunities Research Analyst Access for customization & queries Competitor Analysis with Interactive dashboard Latest News, Updates & Trend analysis Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking Data collection and base year analysis are done using data collection modules with large sample sizes
Ni ngn gn th: cht no c bc Liposome cht lng, th kh nng hp th s cao hn gp nhiu ln bnh thng
If a prospective study confirms the signal, the GLP-1 categorys clinical and commercial footprint extends well beyond metabolic disease into adjuvant cancer therapy
Join our unlimited club today
Sirtuins as molecular targets, mediators, and protective agents in metal-induced toxicity
doi: 10.1016/j.nano.2016.08.004
US$ 21.48
US$ 23.75
US$ 20.05
